Stock ATB ANTIBIOTICE S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Antibiotice S.A.

Equities

ATB

ROATBIACNOR9

Pharmaceuticals

End-of-day quote Bucharest S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.935 RON +0.26% Intraday chart for Antibiotice S.A. 0.00% +38.71%
Feb. 28 Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Antibiotice S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 326.9 341 326.3 406.8 380 936.5
Enterprise Value (EV) 1 452 522.1 481 549.5 459.2 1,001
P/E ratio 9.53 x 11.1 x 12.4 x 13.6 x 9.87 x 11.5 x
Yield 2.05% 5.88% 0.68% 0.53% 1.4% -
Capitalization / Revenue 0.89 x 0.86 x 0.94 x 1.07 x 0.76 x 1.52 x
EV / Revenue 1.23 x 1.32 x 1.39 x 1.45 x 0.92 x 1.63 x
EV / EBITDA 7.6 x 8.27 x 8.08 x 9.36 x 6.65 x 7.99 x
EV / FCF -8.07 x -10.2 x 11.8 x 25.4 x 7.71 x -322 x
FCF Yield -12.4% -9.81% 8.45% 3.93% 13% -0.31%
Price to Book 0.69 x 0.69 x 0.57 x 0.67 x 0.59 x 1.11 x
Nbr of stocks (in thousands) 671,338 671,338 671,338 671,338 671,338 671,338
Reference price 2 0.4870 0.5080 0.4860 0.6060 0.5660 1.395
Announcement Date 3/29/19 3/26/20 4/9/21 4/27/22 4/27/23 4/17/24
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 368.7 395.1 347.2 378.8 497.3 615.3
EBITDA 1 59.49 63.11 59.52 58.68 69.03 125.4
EBIT 1 38.93 41.39 37.42 34.25 46.47 97.42
Operating Margin 10.56% 10.47% 10.78% 9.04% 9.34% 15.83%
Earnings before Tax (EBT) 1 35.09 35.18 28.33 30.3 41.9 91.52
Net income 1 34.3 30.82 26.39 29.94 38.51 81.09
Net margin 9.3% 7.8% 7.6% 7.9% 7.74% 13.18%
EPS 2 0.0511 0.0459 0.0393 0.0446 0.0574 0.1208
Free Cash Flow 1 -56 -51.22 40.65 21.61 59.6 -3.112
FCF margin -15.19% -12.96% 11.71% 5.71% 11.98% -0.51%
FCF Conversion (EBITDA) - - 68.3% 36.84% 86.33% -
FCF Conversion (Net income) - - 154.06% 72.2% 154.74% -
Dividend per Share 2 0.009992 0.0299 0.003306 0.003198 0.007922 -
Announcement Date 3/29/19 3/26/20 4/9/21 4/27/22 4/27/23 4/17/24
1RON in Million2RON
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 125 181 155 143 79.3 64.5
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.102 x 2.869 x 2.599 x 2.431 x 1.148 x 0.5145 x
Free Cash Flow 1 -56 -51.2 40.7 21.6 59.6 -3.11
ROE (net income / shareholders' equity) 7.71% 6.36% 4.89% 5.06% 6.18% 10.2%
ROA (Net income/ Total Assets) 3.8% 3.45% 2.82% 2.43% 3.32% 5.73%
Assets 1 901.7 893.7 934.8 1,230 1,162 1,414
Book Value Per Share 2 0.7000 0.7400 0.8600 0.9000 0.9600 1.260
Cash Flow per Share 2 0 0 0.0100 0 0 0
Capex 1 64.6 69.2 48 29.1 39.9 83
Capex / Sales 17.52% 17.51% 13.82% 7.67% 8.02% 13.49%
Announcement Date 3/29/19 3/26/20 4/9/21 4/27/22 4/27/23 4/17/24
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
ANTIBIOTICE S.A. Stock Antibiotice S.A.
+38.71% 279M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ATB Stock
  4. Financials Antibiotice S.A.